Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg)-Reference-Cited by-同舟云学术

Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg)

Published:2017-11-02 Issue:6 Volume:22 Page:429-438
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Algorta Jaime¹^ORCID,Diaz Maria¹,de Benito Raquel¹,Lefebvre Marc²,Sicard Eric³,Furtado Milton⁴,Regidor Pedro Antonio⁵,Ronchi Celestino⁶

Affiliation:

1. Medical Department, Chemo Group, Azuqueca, Spain;

2. Scientific Department, Altasciences (Algorithme Pharma Inc), Laval, Quebec, Canada;

3. Clinical Department, Altasciences (Algorithme Pharma Inc), Laval, Quebec, Canada;

4. Bioanalytical Department, Altasciences (Algorithme Pharma Inc), Laval, Quebec, Canada;

5. Medical Department (Exeltis), Madrid, Spain;

6. R&D Department, Leon Farma SL, León, Spain

Funder

Centre for Industrial Technological Development

European Regional Development Fund

Agencia de InnovaciÃ³n y FinanciaciÃ³n Empresarial (ADE), Junta de Castilla y Leon

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynecology,Reproductive Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2017.1413179

Reference15 articles.

1. Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing®)

2. Is the Vagina an Adequate Route for the Administration of Hormonal Contraceptives?

3. Current status of contraceptive vaginal rings

4. Nuvaring SPC [product monograph]; 2017 Apr 7 [cited 2017 Jul 7]. Available from: http://www.medicines.org.uk/emc/medicine/21419

5. Ornibel SPC; 2017 Nov 2. Available from: https://db.cbg-meb.nl/IB-teksten/h118961_fsuk.pdf

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and acceptability of intravaginal rings releasing estradiol and progesterone;Climacteric;2023-04-13

2. First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring;Drug Delivery;2023-02-22

3. Micro-molding and Its Application to Drug Delivery;Nano- and Microfabrication Techniques in Drug Delivery;2023

4. Contraception During Perimenopause: Practical Guidance;International Journal of Women's Health;2022-07

5. Advances and future perspectives in epithelial drug delivery;Advanced Drug Delivery Reviews;2022-07